Health and biotech funds may be just what the doctor ordered.
Americans are living longer than ever. To meet the needs of an aging population, the health industry has grown rapidly--creating opportunities for savvy investors.
At the end of 1994, there were only 18 health and biotechnology mutual funds, according to Lipper Analytical Services. Today, there are 48 such funds with assets totalling more than $16.4 billion.